SignatureFD’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.5K | Sell |
527
-251
| -32% | -$12.1K | ﹤0.01% | 2245 |
|
|
2026
Q1 | $40.2K | Buy |
778
+105
| +16% | +$5.35K | ﹤0.01% | 1857 |
|
|
2025
Q4 | $33.4K | Buy |
673
+114
| +20% | +$5.54K | ﹤0.01% | 1874 |
|
|
2025
Q3 | $26.7K | Buy |
559
+28
| +5% | +$1.13K | ﹤0.01% | 1974 |
|
|
2025
Q2 | $16.7K | Buy |
531
+8
| +2% | +$256 | ﹤0.01% | 2137 |
|
|
2025
Q1 | $17.1K | Sell |
523
-38
| -7% | -$1.35K | ﹤0.01% | 2137 |
|
|
2024
Q4 | $20.3K | Hold |
561
| – | – | ﹤0.01% | 2056 |
|
|
2024
Q3 | $17.5K | Hold |
561
| – | – | ﹤0.01% | 2103 |
|
|
2024
Q2 | $15K | Sell |
561
-96
| -15% | -$2.78K | ﹤0.01% | 2096 |
|
|
2024
Q1 | $22.4K | Sell |
657
-7
| -1% | -$208 | ﹤0.01% | 1947 |
|
|
2023
Q4 | $19.2K | Buy |
664
+221
| +50% | +$5.86K | ﹤0.01% | 1948 |
|
|
2023
Q3 | $12.2K | Buy |
443
+22
| +5% | +$670 | ﹤0.01% | 2099 |
|
|
2023
Q2 | $12.7K | Sell |
421
-32
| -7% | -$1.12K | ﹤0.01% | 2134 |
|
|
2023
Q1 | $16.4K | Sell |
453
-2
| -0.4% | -$77 | ﹤0.01% | 1974 |
|
|
2022
Q4 | $16.2K | Hold |
455
| – | – | ﹤0.01% | 1911 |
|
|
2022
Q3 | $15K | Buy |
455
+160
| +54% | +$5.21K | ﹤0.01% | 1889 |
|
|
2022
Q2 | $9K | Buy |
295
+4
| +1% | +$115 | ﹤0.01% | 2190 |
|
|
2022
Q1 | $9K | Hold |
291
| – | – | ﹤0.01% | 2222 |
|
|
2021
Q4 | $8K | Hold |
291
| – | – | ﹤0.01% | 2232 |
|
|
2021
Q3 | $8K | Hold |
291
| – | – | ﹤0.01% | 2191 |
|
|
2021
Q2 | $9K | Hold |
291
| – | – | ﹤0.01% | 2053 |
|
|
2021
Q1 | $8K | Hold |
291
| – | – | ﹤0.01% | 1969 |
|
|
2020
Q4 | $7K | Sell |
291
-34
| -10% | -$732 | ﹤0.01% | 1858 |
|
|
2020
Q3 | $7K | Buy |
325
+198
| +156% | +$4.49K | ﹤0.01% | 1789 |
|
|
2020
Q2 | $3K | Buy |
+127
| New | +$2.81K | ﹤0.01% | 2018 |
|
|
2020
Q1 | – | Sell |
-19
| Closed | – | – | 2440 |
|
|
2019
Q4 | $0 | Hold |
19
| – | – | ﹤0.01% | 2266 |
|
|
2019
Q3 | $1K | Hold |
19
| – | – | ﹤0.01% | 2015 |
|
|
2019
Q2 | $1K | Hold |
19
| – | – | ﹤0.01% | 1947 |
|
|
2019
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 1902 |
|
|
2018
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 1864 |
|
|
2018
Q3 | $1K | Hold |
19
| – | – | ﹤0.01% | 1836 |
|
|
2018
Q2 | $1K | Hold |
19
| – | – | ﹤0.01% | 1852 |
|
|
2018
Q1 | $1K | Buy |
+19
| New | +$793 | ﹤0.01% | 1686 |
|
Other funds holding SUPN
AC
NAMI
SIMG
SignatureFD's SUPN Position: Q2 2026 in Review
SignatureFD reduced its Supernus Pharmaceuticals (SUPN) stake by 32% in Q2 2026, selling an estimated $12.1K and leaving 527 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2245.
SignatureFD first reported a position in SUPN in Q1 2018 and has held it in 33 quarters since. The position peaked at $40.2K in Q1 2026. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- SignatureFD held 527 shares of Supernus Pharmaceuticals worth $24.5K as of Q2 2026.
- SignatureFD sold 251 Supernus Pharmaceuticals shares in Q2 2026, an estimated $12.1K.
- Supernus Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2245 holding.
- SignatureFD first reported a position in Supernus Pharmaceuticals in Q1 2018 and has held it in 33 quarters since.
- SignatureFD's Supernus Pharmaceuticals position peaked at $40.2K in Q1 2026.
- 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.